|Bid||0.00 x 800|
|Ask||0.00 x 4000|
|Day's Range||30.75 - 32.00|
|52 Week Range||15.75 - 32.03|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares retreat after the company releases details about an upcoming phase 3 trial. Should investors be worried, or is this just market noise?
Most investors find it challenging to find companies with prospective double-digit growth rates that are also financially robust. These hidden gems also add meaningful upside to a portfolio, should theRead More...
On a per-share basis, the St. Helier, Jersey-based company said it had a loss of 23 cents. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
NovoCure (NVCR) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.
Investors are always looking for growth in small-cap stocks like NovoCure Limited (NASDAQ:NVCR), with a market cap of US$1.96B. However, an important fact which most ignore is: how financially healthyRead More...
NovoCure Limited’s (NASDAQ:NVCR): NovoCure Limited engages in the development, manufacture, and commercialization of Tumor Treating Fields for the treatment of solid tumors. The US$2.00B market-cap company announced a latest lossRead More...
The St. Helier, Jersey-based company said it had a loss of 12 cents per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
I am going to take a deep dive into NovoCure Limited’s (NASDAQ:NVCR) most recent ownership structure, not a frequent subject of discussion among individual investors. When it comes to ownershipRead More...
CEO of Novocure Ltd (NASDAQ:NVCR) Asaf Danziger sold 336,420 shares of NVCR on 01/12/2018 at an average price of $22.33 a share.
While small-cap stocks, such as NovoCure Limited (NASDAQ:NVCR) with its market cap of $1.81B, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...
Measuring NovoCure Limited’s (NASDAQ:NVCR) track record of past performance is a useful exercise for investors. It enables us to understand whether or not the company has met or exceed expectations,Read More...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Novocure Ltd. Here are 5 ETFs with the largest exposure to NVCR-US. Comparing the performance and risk of Novocure Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
NovoCure Limited (NASDAQ:NVCR), a healthcare equipment and supplies company based in Channel Islands, received a lot of attention from a substantial price increase on the NasdaqGS in the over theRead More...
Jim Cramer sits down with the executive chairman of oncology giant Novocure to get the latest on its cutting-edge tumor therapy.